Manufacturers Life Insurance Company, The Mirati Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$109 Billion
Q4 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$41.99 - $62.38 $3.35 Million - $4.98 Million	-79,763 Reduced 88.47%	10,400 $611,000
Q3 2023 Nov 15, 2023	BUY	$27.8 - $45.35 $973,417 - $1.59 Million	35,015 Added 63.49%	90,163 $3.93 Million
Q2 2023 Aug 11, 2023	BUY	$36.13 - $49.49 $626,060 - $857,562	17,328 Added 45.82%	55,148 $1.99 Million
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $495,445 - $735,711	13,559 Added 35.85%	51,379 $1.91 Million
Q4 2022 Aug 11, 2023	BUY	$41.27 - $98.62 $672,701 - $1.61 Million	16,300 Added 75.74%	37,820 $1.71 Million
Q4 2022 Feb 13, 2023	BUY	$41.27 - $98.62 $672,701 - $1.61 Million	16,300 Added 75.74%	37,820 $1.71 Million
Q3 2022 Aug 11, 2023	SELL	$59.5 - $86.7 $1,844 - $2,687	-31 Reduced 0.14%	21,520 $1.5 Million
Q3 2022 Nov 03, 2022	SELL	$59.5 - $86.7 $1,844 - $2,687	-31 Reduced 0.14%	21,520 $1.51 Million
Q2 2022 Aug 11, 2023	SELL	$39.16 - $88.71 $248,705 - $563,397	-6,351 Reduced 22.76%	21,551 $1.45 Million
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $248,705 - $563,397	-6,351 Reduced 22.76%	21,551 $1.45 Million
Q1 2022 Aug 11, 2023	SELL	$75.82 - $150.97 $1.78 Million - $3.54 Million	-23,477 Reduced 45.69%	27,902 $2.29 Million
Q1 2022 May 20, 2022	BUY	$75.82 - $150.97 $2.12 Million - $4.21 Million	27,902 New	27,902 $2.32 Million
Q2 2021 Aug 12, 2021	SELL	$144.0 - $179.73 $3.32 Million - $4.15 Million	-23,089 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$158.92 - $221.61 $234,565 - $327,096	-1,476 Reduced 6.01%	23,089 $3.96 Million
Q4 2020 Feb 12, 2021	BUY	$162.05 - $240.27 $607,525 - $900,772	3,749 Added 18.01%	24,565 $5.4 Million
Q3 2020 Nov 09, 2020	SELL	$113.26 - $167.27 $26,389 - $38,973	-233 Reduced 1.11%	20,816 $3.46 Million
Q2 2020 Aug 10, 2020	BUY	$72.01 - $120.39 $234,752 - $392,471	3,260 Added 18.33%	21,049 $2.41 Million
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $154,074 - $256,591	2,208 Added 14.17%	17,789 $1.37 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $21,581 - $39,302	-305 Reduced 1.92%	15,581 $2.01 Million
Q3 2019 Nov 12, 2019	BUY	$77.91 - $109.6 $83,753 - $117,820	1,075 Added 7.26%	15,886 $1.34 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $86,498 - $152,248	1,454 Added 10.89%	14,811 $1.53 Million
Q1 2019 May 13, 2019	BUY	$43.65 - $78.95 $48,669 - $88,029	1,115 Added 9.11%	13,357 $979,000
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $12,480 - $18,497	-390 Reduced 3.09%	12,242 $519,000
Q3 2018 Nov 14, 2018	SELL	$47.1 - $62.7 $19,216 - $25,581	-408 Reduced 3.13%	12,632 $595,000
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $339,692 - $683,296	13,040 New	13,040 $643,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account